×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| SAMRAT PHARMACHEM LTD. | 710.96 | -3.99 | 712.03 | -1.29 | 109.0 | 15.3 |
| BHARAT IMMUNOLOGICALS & BIOLOG | NA | NA | NA | NA | 109 | |
| WELCURE DRUGS & PHARMACEUTICAL | 231.21 | 25.39 | 212.11 | 0.33 | 106 | 48.8 |
Samrat Pharmachem Ltd., with Security Code 530125, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 84.0 | 69.2 | 57.5 | 79.7 | 61.7 | 82.7 | 80.8 | 70.2 | 63.7 | 71.2 |
| Expenses | 80.6 | 69.7 | 56.7 | 79.5 | 61.6 | 81.3 | 78.2 | 66.8 | 59.5 | 71.0 |
| Operating Profit | 3.4 | -0.5 | 0.8 | 0.2 | 0.1 | 1.4 | 2.6 | 3.4 | 4.2 | 0.2 |
| OPM % | 4.08% | -0.71% | 1.34% | 0.29% | 0.18% | 1.64% | 3.2% | 4.79% | 6.55% | 0.26% |
| Other Income | 0.1 | 0.0 | 0.4 | 0.3 | 0.4 | 0.3 | 0.6 | 0.5 | 0.0 | -0.1 |
| Interest | 0.6 | 0.2 | 0.2 | 0.1 | 0.2 | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Profit before tax | 2.8 | -0.8 | 0.8 | 0.2 | 0.1 | 1.4 | 2.8 | 3.5 | 3.9 | -0.3 |
| Tax % | -24.4% | -5.8% | -18.9% | -179.7% | 144% | 0.4% | -26.7% | -24.4% | -28.8% | 0% |
| Net Profit | 2.1 | -0.7 | 0.6 | -0.2 | 0.3 | 1.4 | 2.1 | 2.7 | 2.8 | -0.4 |
| EPS in Rs | 6.78 | -2.41 | 1.98 | -0.61 | 1.11 | 4.52 | 6.68 | 8.61 | 9.01 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 20% |
| 3 Years: | 16% |
| TTM: | 11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 24% |
| 5 Years: | 7% |
| 3 Years: | -26% |
| TTM: | 44450% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 37% |
| 3 Years: | -3% |
| 1 Year: | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|